Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

virtualization

Roche - Basel

Roche drops superbug partnership with Polyphor

But adds inflammation research agreement with Proximagen

Roche Basel Switzerland

Roche gets EU green light for Cotellic

Approved in combination with Zelboraf for melanoma

Roche Basel Switzerland

Roche posts positive Cotellic data ahead of anticipated EU approval

Comes after FDA and Swiss approvals and CHMPrecommendation

Roche Basel Switzerland

Roche exits four manufacturing sites with loss of 1,200 jobs

Closes three Europeans plants and one US facility

- PMLiVE

FDA approves Exelixis/Genentech’s melanoma combo Cotellic

Willprovide the first direct competition to Novartis' Mekinist in the US

- PMLiVE

GSK bags FDA approval for severe asthma drug Nucala

Drug to be launched as soon as possible

Roche Basel Switzerland

Price cut keeps Kadcyla on CDF

Comes after pressure from campaign groups

- PMLiVE

Roche appoints new UK general manager

Richard Erwin was previously the company's general manager for Belgium

Roche Basel Switzerland

Roche’s Kadcyla fails in gastric cancer trial

Results are a major blow to the firm's ambition of expanding the indications for its breast cancer drug

- PMLiVE

Roche faces Kadcyla pricing pressure in the UK

Leading breast cancer charity calls on firmto reduce the drug's cost

Roche Basel Switzerland

Roche’s investigational drug first to show efficacy in MS

Ocrelizumab shows positive results in large phase III study

Roche's Perjeta pertuzumab

Roche’s Perjeta launches in UK for early breast cancer

Says nearly 2,000 women each year could benefit from its drug

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links